WASHINGTON, D.C. — The Food and Drug Administration (FDA) announced that Abbott has initiated a voluntary recall for a specific batch of FreeStyle Libre® 3 sensors distributed in the U.S. … ...

The FreeStyle Libre 3 technology provides continuous, real-time glucose readings... ABBOTT PARK, Ill., Sept. 28, 2020/ PRNewswire/-- Abbott, the worldwide leader in continuous glucose monitoring ...

FreeStyle Libre 3 Sensor Class I Recall; Second OTC CGM Cleared; ... (Tresiba) over 52 weeks in adults with type 2 diabetes, according to the QWINT-1 and -3 trials, respectively.

The FreeStyle Libre 3’s reader and app were unaffected, as were other products in the FreeStyle Libre line. A company spokesperson said Abbott estimates the issue will affect less than 1% of ...

A small number of sensors that read blood sugar levels continuously may give incorrect info. Here's how to check your FreeStyle Libre 3 for a replacement.

Credit: Abbott. The FreeStyle Libre 3 reader is a standalone, small handheld device that displays real-time glucose readings. The Food and Drug Administration (FDA) has cleared a standalone reader ...

Abbott (NYSE: ABT) today announced that its latest generation of sensor-based glucose monitoring technology, the FreeStyle Libre 3 Plus* sensor, is now available to Canadians living with diabetes.